The effectiveness of peroneal nerve functional electrical simulation for the reduction of bradykinesia in Parkinson’s disease: A feasibility study for a randomised control trial

Abstract

Objectives:

To assess the feasibility of a multi-site randomised controlled trial to evaluate the effect of functional electrical stimulation on bradykinesia in people with Parkinson’s disease.

Design:

A two-arm assessor blinded randomised controlled trial with an 18 weeks intervention period and 4 weeks post-intervention follow-up.

Setting:

Two UK hospitals; a therapy outpatient department in a district general hospital and a specialist neuroscience centre.

Participants:

A total of 64 participants with idiopathic Parkinson’s disease and slow gait <1.25 ms⁻¹.

Interventions:

Functional electrical stimulation delivered to the common peroneal nerve while walking in addition to standard care compared with standard care alone.

Main measures:

Feasibility aims included the determination of sample size, recruitment and retention rates, acceptability of the protocol and confirmation of the primary outcome measure. The outcome measures were 10 m walking speed, Unified Parkinson’s Disease Rating Scale (UPDRS), Mini Balance Evaluation Systems Test, Parkinson’s Disease Questionnaire-39, EuroQol 5-dimension 5-level, New Freezing of Gait questionnaire, Falls Efficacy Score International and falls diary. Participants opinion on the study design and relevance of outcome measures were evaluated using an embedded qualitative study.

Results:

There was a mean difference between groups of 0.14 ms⁻¹ (CI 0.03, 0.26) at week 18 in favour of the treatment group, which was maintained at week 22, 0.10 ms⁻¹ (CI –0.05, 0.25). There was a mean difference in UPDRS motor examination score of –3.65 (CI –4.35, 0.54) at week 18 which was lost at week 22 –0.91 (CI –2.19, 2.26).

Conclusion:

The study design and intervention were feasible and supportive for a definitive trial. While both the study protocol and intervention were acceptable, recommendations for modifications are made.

Keywords

Parkinson’s disease functional electrical stimulation bradykinesia

Get full access to this article

View all access options for this article.

References

Cioni

Richards

Malouin

, et al. Characteristics of the electromyographic patterns of lower limb muscles during gait in patients with Parkinson’s disease when OFF and ON L-Dopa treatment. Ital J Neurol Sci 1997; 18: 195–208.

National Institute for Health and Care Excellence (NICE). Functional electrical stimulation for drop foot of central neurological origin, http://www.nice.org.uk/Guidance/IPG278 (2009, accessed 13 November 2020).

Taylor

Humphreys

Swain

The long term cost-effectiveness of the use of functional electrical stimulation for the correction of dropped foot due to upper motor neuron lesion. J Rehabil Med 2013; 45: 154–160.

Mann

Finn

Taylor

PN.

A pilot study to investigate the feasibility of electrical stimulation to assist gait in Parkinson’s disease. Neuromodulation 2008; 11(2): 143–149.

Popa

Taylor

Functional electrical stimulation may reduce bradykinesia in Parkinson’s disease: a feasibility study. J Rehabil Assist Technol Eng 2015; 2: 2055668315607836.

Goetz

Tilley

Stephanie

, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPARKINSON’SRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23(15): 2129–2170.

Peto

Jenkinson

Fitzpatrick

, et al. PDQ-39: a review of the development, validation and application of a Parkinson’s disease quality of life questionnaire and its associated measures. J Neurol 1998; 245(Suppl. 1): S10–S14.

Schrag

Selai

Jahanshahi

, et al. The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 2000; 69(1): 67–73.

Nieuwboer

Rochester

Herman

, et al. Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson’s disease and their carers. Gait Posture 2009; 30(4): 459–463.

10.

Lamb

Jorstad-Stein

Hauer

, et al. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc 2005; 53: 1618–1622.

11.

Delbaere

JCT

. The Falls Efficacy Scale International (FES-I). A comprehensive longitudinal validation study. Age Ageing 2010; 39: 210–216.

12.

King

Priest

Salarian

, et al. Comparing the Mini-BESTest with the Berg Balance Scale to evaluate balance disorders in Parkinson’s disease. Parkinsons Dis 2012; 2012: 375419.

13.

Schulz

Grimes

DA.

Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 2002; 359: 781–785.

14.

Crabtree

Lodge

Emmerson

A review of pedestrian walking speeds and time needed to cross the road. Published project report PPR700, Transport Research Laboratory, 2014.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.17 MB

0.66 MB